CARBONARA, Giuseppe Gerardo
 Distribuzione geografica
Continente #
NA - Nord America 3.552
EU - Europa 935
AS - Asia 335
SA - Sud America 6
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.834
Nazione #
US - Stati Uniti d'America 3.535
CN - Cina 270
SE - Svezia 246
UA - Ucraina 168
IT - Italia 127
DE - Germania 119
FI - Finlandia 93
FR - Francia 77
GB - Regno Unito 57
IN - India 26
IE - Irlanda 17
IR - Iran 14
BE - Belgio 13
CA - Canada 12
CH - Svizzera 7
TR - Turchia 6
KR - Corea 5
VN - Vietnam 5
BR - Brasile 4
HK - Hong Kong 4
JM - Giamaica 4
AU - Australia 3
ID - Indonesia 3
NL - Olanda 3
A1 - Anonimo 2
CL - Cile 2
JP - Giappone 2
LT - Lituania 2
BG - Bulgaria 1
DK - Danimarca 1
ES - Italia 1
LV - Lettonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
Totale 4.834
Città #
Jacksonville 393
Fairfield 378
Chandler 369
Woodbridge 362
Ashburn 231
Houston 221
Cambridge 185
Nyköping 182
Ann Arbor 171
Seattle 138
Wilmington 129
Nanjing 91
Lawrence 88
Roxbury 88
Princeton 67
Bari 59
Des Moines 59
Boardman 52
Inglewood 40
Beijing 39
New York 36
Marseille 32
Nanchang 24
Brooklyn 20
Hebei 20
Jiaxing 19
Tianjin 18
Dublin 17
Changsha 16
San Diego 15
Brussels 13
Shenyang 13
Washington 12
Paris 11
Augusta 10
Leawood 10
Toronto 9
Dearborn 8
London 8
Long Beach 8
Los Angeles 8
Ardabil 7
Helsinki 7
Lausanne 7
Rome 7
San Mateo 7
Boydton 6
Haikou 6
San Francisco 6
Auburn Hills 5
Genova 5
Mumbai 5
Pune 5
Bologna 4
Dong Ket 4
Guangzhou 4
Guys Hill 4
Napoli 4
Norwalk 4
Zhengzhou 4
Brahmapur 3
Cleveland 3
Jinan 3
Kunming 3
Redwood City 3
Brasília 2
Camden 2
Cassano Magnago 2
Chennai 2
Delhi 2
East Hartford 2
Hefei 2
Hong Kong 2
Indiana 2
Istanbul 2
Kenmore 2
Latina 2
Lebak Bulus 2
Lewisham 2
Lonato 2
Monmouth Junction 2
Ningbo 2
Parma 2
Plungė 2
Prescot 2
Redmond 2
Salerno 2
Simi Valley 2
Sydney 2
Tappahannock 2
Tehran 2
Tokyo 2
Acton 1
Barletta 1
Bisceglie 1
Bogor 1
Central 1
Chicago 1
Chieti 1
Chongqing 1
Totale 3.847
Nome #
Synthesis, biological evaluation, and molecular modeling investigation of chiral 2-(4-chloro-phenoxy)-3-phenyl-propanoic acid derivatives with PPARα and PPARγ agonist activity 126
An efficient synthesis of the optically active isomers of 2H-1,4-benzoxazine derivatives, novel KATP channel modulators 126
Kidney CLC-K Chloride Channels Show Differential Pharmacological Profiles Depending on the Heterologous Expression System 125
Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists 115
Convenient synthesis of some 3-phenyl-1-benzofuran-2-carboxylic acid derivatives as new potential inhibitors of CLC-Kb channels 114
Comparative LC Enantioseparation of Novel PPAR Agonists on Cellulose- and Amylose-Based Chiral Stationary Phases 113
Activation and inhibition of kidney CLC-K chloride channels by fenamates 106
Repositioning of Endonuclear Receptors Binders as Potential Antibacterial and Antifungal Agents. Eptyloxìm: A Potential and Novel Gyrase B and Cytochrome Cyp51 Inhibitor 97
Carboxylic acids and skeletal muscle chloride channel conductance: Effects on the biological activity induced by the introduction of an aryloxyalkyl group α to the carboxylic function of 4-chloro-phenoxyacetic acid 97
Kidney CLC-K Chloride Channels Inhibitors: Definition of Novel Structural Requirements and Efficacy in CLC-K Polymorphism Associated with Hypertension 96
Probiotic and Tea Tree Oil Treatments Improve Therapy of Vaginal Candidiasis: A Preliminary Clinical Study 91
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 88
ChemInform Abstract: Convenient Synthesis of Some 3-Phenyl-1-benzofuran-2-carboxylic Acid Derivatives as New Potential Inhibitors of CLC-Kb Channels. 86
Molecular determinants for the activating/blocking actions of the 2H-1,4-benzoxazine derivatives, a class of potassium channel modulators targeting the skeletal muscle KATP channels 86
Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials 84
Enantiomeric separation of 2-aryloxyalkyl- and 2-arylalkyl-2-aryloxyacetic acids on a Penicillin G Acylase-based chiral stationary phase: influence of the chemical structure on retention and enantioselectivity 75
Comparative analysis of enantioselective separation of novel PPAR agonists by HPLC on cellulose- and amylose-based chiral stationary phases 72
Might the observed a2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 72
Synthesis, Biological Evaluation, and Molecular Modeling Investigation of Chiral Phenoxyacetic Acid Analogues with PPARalpha and PPARgamma Agonist Activity 72
Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+ - deficient rats 70
Chemical studies on Drug Metabolism (part II): N-demethylation and N-oxidation of some alicyclic amines by RuO4 68
Attività biologica sui canali KATP del muscolo scheletrico nativo di nuovi e potenti derivati delle 2H-1,4-Benzossazine 67
null 66
Elucidation of the enantioselective recognition mechanism of a penicillin G acylase-based chiral stationary phase towards a series of 2-aryloxy-2-arylacetic acids 65
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 65
KIDNEY CLC-K CHLORIDE CHANNELS SHOW DIFFERENTIAL PHARMACOLOGICAL PROFILES DEPENDING ON THE HETEROLOGOUS EXPRESSION SYSTEM 64
Exploring the molecular basis of the enantioselective binding of penicillin G acylase towards a series of 2 aryloxyalkanoic acids: A docking and molecular dynamics study 64
Design, synthesis and biological evaluation of a class of bioisosteric oximes of the novel dual peroxisome proliferator-activated receptor alpha/gamma ligand LT175 64
Analisi Farmaceutica 63
Molecular switch for CLC-K Cl– channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands 62
2-(9-Antryl)alcanoic acids as chloride channel modulators 60
Sintesi di una nuova serie di acidi 2-benzofuran-carbossilici a potenziale attività bloccante dei canali al cloro voltaggio-dipendenti CLC-K 59
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/non-peptidyl structure 59
null 56
Ossidazione di ammine policicliche terziarie con RuO4 55
Studio delle proprietà enentioselettive di una fase stazionaria chirale a base di PGA 55
Allyphenyline Analogues Potentially Useful in the Management of Chronic Pain and Opioid Addiction 52
Molecular determinants for nuclear receptors selectivity: chemometric analysis, dockings and site-directed mutagenesis of dual peroxisome proliferator-activated receptors alpha/gamma agonists 52
INNOVATIVE METHODOLOGIES IN NANOTECHNOLOGY FOR THE PREVENTION OF BACTERIAL DISEASES 51
Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid 51
BIOLOGICAL ACTIVITY OF NEW POTENT 2H-1,4-BENZOXAZINE DERIVATIVES ON THE NATIVE SKELETAL MUSCLE KATP CHANNEL 50
Agonisti dei Recettori Nucleari PPARs come Potenziali Nuovi Agenti Terapeutici per il Trattamento della Sindrome Metabolica 49
Calcium activated K+ channel as a target of prompt-to-use drugs in neuromuscular disorders 49
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation. 48
Block of renal CLC-K channels by phenoxy-alkyl derivatives of clofibric acid 48
Selective oxidation of nitrogen organic compounds 47
Chemical studies on Drug Metabolism: Oxidation with ruthenium tetroxide of some medicinal alicyclic N-metylamines 46
Tissue specific action of the 2-(propyl)-1,4-benzoxazine on pancreatic beta cell ATP-sensitive potassium channels 45
Structural nucleotide analogs are potent activators/inhibitors of pancreatic beta-cell KATP channels: an emerging mechanism supporting their use as anti-diabetic drugs. 45
Synthesis, biological evaluation and molecular investigation of fluorinated peroxisome proliferator-activated receptors alpha/gamma dual agonists 43
SINTESI E VALUTAZIONE BIOLOGICA DI DERIVATI SEMI-RIGIDI DELL'ACIDO 2-(4-CLOROFENOSSI)-3-FENIL-PROPANOICO COME BLOCCANTI DEI CANALI AL CLORO VOLTAGGIO-DIPENDENTI CLC-K 42
Oxidation of tertiary polycyclic amines by RuO4 41
MOLECULAR SPATIAL GEOMETRY OF CLC-K LIGANDS: OPTIMAL REQUIREMENTS TOWARDS HIGH AFFINITY CHANNEL BLOCK. 40
(contributo in convegno) MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY; CHEMOMETRIC ANALYSIS, DOCKINGS AND SITE-DIRECTED MUTAGENESIS OF DUAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS α/γ AGONISTS 39
Selective oxidation of Nitrogen organic compounds by Ruthenium tetroxide 38
Enantioselective properties of Penicillin G Acylase: Liquid Crhomatographic studies end docking simulations 38
null 38
null 37
null 37
Progettazione e sintesi di nuovi agenti antimicrobici e studio dell'attività biologica in associazione con differenti olii essenziali 35
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW ANALOGS OF THE DUAL PPARα/γ AGONIST LT175. 35
Design, synthesis and biological evaluation of a dimeric analog of the dual PPARα/γ agonist 2-(4-phenyl-phenoxy)-3-phenyl-propanoic acid. 32
Dal brodo primordiale alla farmacogenomica 32
null 32
Effects on skeletal muscle chloride channel conductance of a-aryloxyalkyl-4-chlorophenoxyacetic acids 31
H-1-NMR determination of the enantiomeric excess of the antiarrhythmic drug Mexiletine by using mandelic acid analogues as chiral solvating agents 31
null 30
null 30
null 29
AGONISTI DEI RECETTORI NUCLEARI PPARs COME POTENZIALI NUOVI AGENTI TERAPEUTICI PER IL TRATTAMENTO DELLA SINDROME METABOLICA. 29
EFFETTI DERIVANTI DALL'INTRODUZIONE DI SOSTITUENTI SUL NUCLEO DIFENILICO DEL COMPOSTO LT175, AGONISTA DUALE DEI RECETTORI NUCLEARI PPARalfa E PPARgamma 29
Traduzione Capitoli 1-9 28
null 27
null 25
null 25
Determinanti Molecolari della Selettività di Recettori Nucleari: Analisi Chemiometrica e Docking di Agonisti Selettivi di Recettori PPARs 25
NEW CHIRAL CLOFIBRIC ACID ANALOGS AS LIGANDS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) alpha AND gamma 24
null 23
null 23
Effetti sulla conduttanza dei canali al cloro della muscolatura scheletrica indotti dall’introduzione di un sostituente arilossialchilico in a alla funzione carbossilica dell’acido 4-cloro-fenossiacetico 23
null 22
null 22
Evaluation of biophysical and pharmacological properties of chloride channels belonging to ClC family by the use of chiral clofibric acid derivatives 22
null 22
Molecular spatial geometry of CLC-K ligands: optimal requirements towards high affinity channel block 21
null 21
null 20
Molecular spatial geometry of CLC-K ligands: optimal requirements towards high affinity channel block 20
null 20
Novel dual PPARalpha/gamma Agonists, as hypoglycemic and antidiabetic agents 19
Dimeric analogs of the dual PPARα/γ agonist LT-175: design, synthesis and biological evaluation 19
null 18
Synthesis and biological screening of new chiral a-aryloxy-alkanoic acids as PPARs agonists 18
Synthesis and biological screening of new chiral 2-(4-chloro-phenoxy)-3-phenylpropanoic acid analogs as potential PPAR alpha/gamma dual agonists 18
null 17
EVALUATION OF BIOPHYSICAL AND PHARMACOLOGICAL PROPERTIES OF CHLORIDE CHANNELS BELONGING TO CLC FAMILY BY THE USE OF CHIRAL CLOFIBRIC ACID DERIVATIVES. 17
MOLECULAR DETERMINANTS FOR NUCLEAR RECEPTORS SELECTIVITY: CHEMIOMETRIC ANALYSIS AND DOCKING OF DUAL PPAR AGONISTS. 17
NEW CHIRAL DERIVATIVES OF 2-(4-PHENYL-PHENOXY)-3-PHENYLPROPANOIC ACID WITH PPARalpha/gamma DUAL ACTIVITY. 16
Synthesis and biological evaluation of new fluorinated analogues with PPARα and PPARγ agonist activity 15
Molecular spatial geometry of CLC-K ligands: optimal requirements towards high affinity channel block 14
Totale 4.905
Categoria #
all - tutte 17.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019246 0 0 0 0 0 0 0 0 0 0 117 129
2019/20201.188 248 74 24 80 120 64 147 77 145 52 127 30
2020/2021779 138 27 59 40 80 13 59 33 73 110 93 54
2021/2022601 23 89 1 22 25 23 29 28 24 27 119 191
2022/20231.064 185 68 60 93 140 146 10 110 214 4 14 20
2023/2024360 26 66 21 25 50 103 23 24 11 11 0 0
Totale 4.983